EC Number   |
Inhibitors |
Structure |
|---|
   2.5.1.68 | (1-[[(3E)-4,8-dimethylnona-3,7-dien-1-yl](hydroxy)phosphoryl]-1-ethylpropyl)phosphonic acid |
- |
   |
| 2.5.1.68 | (E)-1-ethyl-1-[(4,8-dimethyl-3,7-nonadienyl)hydroxyphosphoryl] propyl phosphonic acid tripotassium salt |
- |
|
| 2.5.1.68 | (E)-geranyl diphosphate analogues |
design and synthesis of substrate analogue inhibitors, overview |
|
| 2.5.1.68 | citronellyl diphosphate |
- |
|
| 2.5.1.68 | EDTA |
complete inhibition at 10 mM |
|
| 2.5.1.68 | Mn2+ |
optimal at 0.1 mM, the enzyme absolutely requires a divalent cation, inhibition by Mn2+ at higher concentration of 5.0 mM |
|
| 2.5.1.68 | more |
no inhibition by dipotassium salt of (E)-1-[(3,7-methyl-2,6-octadienyl)aminocarbonyl] propyl phosphonic acid, dipotassium salt of (E)-1-[[(3,7-methyl-2,6-octadienyl)oxy]aminocarbonyl] propyl phosphonic acid, and dipotassium salt of (E)-2-oxo-2-[(3,7-methyl-2,6-octadienyl)oxy-[amino]ethyl]phosphonic acid |
|
